IFN-γ-induced iNOS expression in mouse regulatory macrophages prolongs allograft survival in fully immunocompetent recipients

Molecular Therapy

Volumn 21, Issue 2, 2013, Pages 409-422

  Riquelme, Paloma ^a,b   Tomiuk, Stefan ^b,c   Kammler, Anja ^a   Fändrich, Fred ^b,d   Schlitt, Hans J ^a,b   Geissler, Edward K ^a,b   Hutchinson, James A ^a,b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b European Union   (Belgium)

^c MILTENYI BIOTEC GMBH   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGENIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL SURFACE; CELL THERAPY; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART GRAFT; HUMAN; IMMUNOCOMPETENCE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MITOGENESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REGULATORY MACROPHAGE; SERUM; T LYMPHOCYTE;

EID: 84873406485     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.168     Document Type: Article

References (53)

1. Halloran, PF (2004). Immunosuppressive drugs for kidney transplantation. N Engl J Med 351: 2715-2729.
2. Meier-Kriesche, HU, Schold, JD, Srinivas, TR and Kaplan, B (2004). Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4: 378-383.
3. rd, Di Cocco, P, Cocco, PD et al. (2010). Clinical operational tolerance after renal transplantation: current status and future challenges. Ann Surg 252: 915-928.
4. Sagoo, P, Perucha, E, Sawitzki, B, Tomiuk, S, Stephens, DA, Miqueu, P et al. (2010). Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 120: 1848-1861.
5. Newell, KA, Asare, A, Kirk, AD, Gisler, TD, Bourcier, K, Suthanthiran, M et al.; Immune Tolerance Network ST507 Study Group. (2010). Identifcation of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 120: 1836-1847.
6. Leslie, M (2011). Immunology. Regulatory T cells get their chance to shine. Science 332: 1020-1021.
7. Bluestone, JA (2011). Mechanisms of tolerance. Immunol Rev 241: 5-19.
8. Edinger, M and Hoffmann, P (2011). Regulatory T cells in stem cell transplantation: strategies and frst clinical experiences. Curr Opin Immunol 23: 679-684.
9. Hutchinson, JA, Riquelme, P, Sawitzki, B, Tomiuk, S, Miqueu, P, Zuhayra, M et al. (2011). Cutting Edge: Immunological consequences and traffcking of human regulatory macrophages administered to renal transplant recipients. J Immunol 187: 2072-2078.
10. Hutchinson, JA, Riquelme, P and Geissler, EK (2012). Human regulatory macrophages as a cell-based medicinal product. Curr Opin Organ Transplant 17: 48-54.
11. Hutchinson, JA, Riquelme, P, Geissler, EK and Fändrich, F (2011). Human regulatory macrophages. Methods Mol Biol 677: 181-192.
12. Gordon, S and Taylor, PR (2005). Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964.
13. Biswas, SK and Mantovani, A (2010). Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11: 889-896.
14. Martinez, FO, Helming, L and Gordon, S (2009). Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27: 451-483.
15. Mosser, DM and Edwards, JP (2008). Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
16. Martinez, FO, Gordon, S, Locati, M and Mantovani, A (2006). Transcriptional profling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177: 7303-7311.
17. Mantovani, A, Sica, A and Locati, M (2007). New vistas on macrophage differentiation and activation. Eur J Immunol 37: 14-16.
18. Reis e Sousa (2006). Dendritic cells in a mature age. Nat Rev Immunol 6: 476-483.
19. Taylor, PR, Martinez-Pomares, L, Stacey, M, Lin, HH, Brown, GD and Gordon, S (2005). Macrophage receptors and immune recognition. Annu Rev Immunol 23: 901-944.
20. Lees, JR, Azimzadeh, AM and Bromberg, JS (2011). Myeloid derived suppressor cells in transplantation. Curr Opin Immunol 23: 692-697.
21. + DCs. J Exp Med 206: 3115-3130.
22. Waddell, SJ, Popper, SJ, Rubins, KH, Griffths, MJ, Brown, PO, Levin, M et al. (2010). Dissecting interferon-induced transcriptional programs in human peripheral blood cells. PLoS ONE 5: e9753.
23. Riquelme, P, Gövert, F, Geissler, EK, Fändrich, F and Hutchinson, JA (2009). Human transplant acceptance-inducing cells suppress mitogen-stimulated T cell proliferation. Transpl Immunol 21: 162-165.
24. Chappert, P and Schwartz, RH (2010). Induction of T cell anergy: integration of environmental cues and infectious tolerance. Curr Opin Immunol 22: 552-559.
25. Murray, PJ and Wynn, TA (2011). Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11: 723-737.
26. Wyburn, KR, Jose, MD, Wu, H, Atkins, RC and Chadban, SJ (2005). The role of macrophages in allograft rejection. Transplantation 80: 1641-1647.
27. Jang, HS, Kim, J, Park, YK and Park, KM (2008). Infltrated macrophages contribute to recovery after ischemic injury but not to ischemic preconditioning in kidneys. Transplantation 85: 447-455.
28. Nakamura, T, Abu-Dahab, R, Menger, MD, Schäfer, U, Vollmar, B, Wada, H et al. (2005). Depletion of alveolar macrophages by clodronate-liposomes aggravates ischemia-reperfusion injury of the lung. J Heart Lung Transplant 24: 38-45.
29. Devey, L, Ferenbach, D, Mohr, E, Sangster, K, Bellamy, CO, Hughes, J et al. (2009). Tissue-resident macrophages protect the liver from ischemia reperfusion injury via a heme oxygenase-1-dependent mechanism. Mol Ther 17: 65-72.
30. Broichhausen, C, Riquelme, P, Geissler, EK and Hutchinson, JA (2012). Regulatory macrophages as therapeutic targets and therapeutic agents in solid organ transplantation. Curr Opin Organ Transplant 17: 332-342.
31. + regulatory T cells: a potential explanation for the blood-transfusion effect. Transplantation 76: 449-455.
32. Morelli, AE and Larregina, AT (2010). Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells. Apoptosis 15: 1083-1097.
33. Steinman, RM, Turley, S, Mellman, I and Inaba, K (2000). The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 191: 411-416.
34. + dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens. J Immunol 182: 4127-4136.
35. + and IL-10-producing splenic macrophages and maintained by T regulatory cells. J Immunol 187: 2405-2417.
36. Morelli, AE, Larregina, AT, Shufesky, WJ, Zahorchak, AF, Logar, AJ, Papworth, GD et al. (2003). Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101: 611-620.
37. Quezada, SA, Fuller, B, Jarvinen, LZ, Gonzalez, M, Blazar, BR, Rudensky, AY et al. (2003). Mechanisms of donor-specifc transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation. Blood 102: 1920-1926.
38. Hancock, WW, Sayegh, MH, Zheng, XG, Peach, R, Linsley, PS and Turka, LA (1996). Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 93: 13967-13972.
39. Pearson, TC, Madsen, JC, Larsen, C P, Morris, PJ and Wood, KJ (1992). Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody. Transplantation 54: 475-483.
40. Niimi, M, Roelen, DL, Witzke, O, van Rood, JJ, Claas, FH and Wood, KJ (2000). The importance of H2 haplotype sharing in the induction of specifc unresponsiveness by pretransplant blood transfusions. Transplantation 69: 411-417.
41. Garcia, MR, Ledgerwood, L, Yang, Y, Xu, J, Lal, G, Burrell, B et al. (2010). Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J Clin Invest 120: 2486-2496.
42. Davies, JK (2011). Costimulatory blockade with monoclonal antibodies to induce alloanergy in donor lymphocytes. Int J Hematol 93: 594-601.
43. Andreola, G, Chittenden, M, Shaffer, J, Cosimi, AB, Kawai, T, Cotter, P et al. (2011). Mechanisms of donor-specifc tolerance in recipients of haploidentical combined bone marrow/kidney transplantation. Am J Transplant 11: 1236-1247.
44. + immunoregulatory T cells is antigen nonspecifc. J Immunol 164: 183-190.
45. Dalton, DK, Pitts-Meek, S, Keshav, S, Figari, IS, Bradley, A and Stewart, TA (1993). Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259: 1739-1742.
46. Bogdan, C (2011). Regulation of lymphocytes by nitric oxide. Methods Mol Biol 677: 375-393.
47. Pacher, P, Beckman, JS and Liaudet, L (2007). Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424.
48. Lu, L, Bonham, CA, Chambers, FG, Watkins, SC, Hoffman, RA, Simmons, RL et al. (1996). Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J Immunol 157: 3577-3586.
49. Ren, G, Su, J, Zhao, X, Zhang, L, Zhang, J, Roberts, AI et al. (2008). Apoptotic cells induce immunosuppression through dendritic cells: critical roles of IFN-gamma and nitric oxide. J Immunol 181: 3277-3284.
50. + regulatory T cells. Eur J Immunol 38: 2512-2527.
51. Hutchinson, JA, Brem-Exner, BG, Riquelme, P, Roelen, D, Schulze, M, Ivens, K et al. (2008). A cell-based approach to the minimization of immunosuppression in renal transplantation. Transpl Int 21: 742-754.
52. Hutchinson, JA, Riquelme, P, Brem-Exner, BG, Schulze, M, Matthäi, M, Renders, L et al. (2008). Transplant acceptance-inducing cells as an immune-conditioning therapy in renal transplantation. Transpl Int 21: 728-741.
53. Corry, RJ, Winn, HJ and Russell, PS (1973). Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 16: 343-350.